Logan Recognized As The Highest Grossing Wolverine Installment Ever

Following an epic three week run at cinemas around the country and indeed the globe, Logan is now the chief Wolverine movie of them all. Going past two titles in 2009's X-Men Origins: Wolverine and 2013's The Wolverine, this weekend's haul of $17.5m now drives the title for the Marvel installment up to a domestic total of $184m.

Origins managed well despite it's poor reviews to amass $180m in the United States. While the follow up four years later could only muster $132.5m. The global numbers also make for improved reading, with 2017's blockbuster eclipsing Origins ($373m) and The Wolverine ($415m) with a staggering $481m.

Setting The Pace To All Contenders In 2017

Logan X-Men Comic

It isn't only within the Marvel parameters that the flick is enjoying it's own slice of history. No other release in theaters has garnered more in 2017. A direct result from being the widest released R rated film ever. 20th Century Fox initially had reservations about the direction of production but once lead star Hugh Jackman and director James Mangold argued the case in the affirmative, they were given the creative license to go down that path.

This stellar performance lends weight to the idea that the character of X-23 could set the scene for a sequence of future titles. A concept that both Mangold and Patrick Stewart have embraced in public. Whatever the case may be, Logan has forever changed the landscape for what a superhero movie should be and can be.

Sir Stewart Opens Up On Pot Use For Ongoing Illness

Professor X in Logan

While he has kept details of his private illness away from the spotlight, Patrick Stewart explained that the use of cannabis helps to alleviate arthritis in his hands. Playing the iconic Charles Xavier for the final time, the Englishman understands that it is still something of a taboo subject to touch upon, but argues that the results are there for all to see.

“Two years ago, in Los Angeles, I was examined by a doctor and given a note which gave me legal permission to purchase, from a registered outlet, cannabis-based products, which I was advised might help the ortho-arthritis in both my hands,” remarked Patrick. “This, it would seem, is a genetically-based condition. My mother had badly distorted and painful hands. I purchased an ointment, spray and edibles. The ointment, while providing some relief from the discomfort, was too greasy to use during daytime and so I only use it at night.”

Making the statement to Oxford University, Stewart is pushing the cause for medical cannabis.

"I have had no negative side effects from this treatment and the alternative would have been to continue taking NSAID’s, Advil, Aleve and Naproxen, which are known to be harsh on the liver and to cause acid reflux. This is an important step forward for Britain in a field of research that has for too long been held back by prejudice, fear and ignorance. I believe this programme of research might result in benefits for people like myself as well as millions of others.”